Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol
Publication
, Conference
Richardson, PG; Smith, A; Kernan, NA; Grupp, SA; Arai, S; Triplett, BM; Haut, PR; Chan, K; Symons, HJ; Horn, BN; Gillio, AP; Boyer, M ...
Published in: Blood
November 16, 2012
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 16, 2012
Volume
120
Issue
21
Start / End Page
738 / 738
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Richardson, P. G., Smith, A., Kernan, N. A., Grupp, S. A., Arai, S., Triplett, B. M., … Soiffer, R. J. (2012). Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol. In Blood (Vol. 120, pp. 738–738). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.738.738
Richardson, Paul G., Angela Smith, Nancy A. Kernan, Stephan A. Grupp, Sally Arai, Brandon M. Triplett, Paul R. Haut, et al. “Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol.” In Blood, 120:738–738. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.738.738.
Richardson PG, Smith A, Kernan NA, Grupp SA, Arai S, Triplett BM, et al. Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol. In: Blood. American Society of Hematology; 2012. p. 738–738.
Richardson, Paul G., et al. “Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol.” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 738–738. Crossref, doi:10.1182/blood.v120.21.738.738.
Richardson PG, Smith A, Kernan NA, Grupp SA, Arai S, Triplett BM, Haut PR, Chan K, Symons HJ, Horn BN, Gillio AP, Boyer M, Krishnan A, Lehmann LE, Martin PL, Mineishi S, Shore TB, Simms-Waldrip T, Antin JH, Hannah AL, Hume R, Tudone E, Heringa C, Soiffer RJ. Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol. Blood. American Society of Hematology; 2012. p. 738–738.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 16, 2012
Volume
120
Issue
21
Start / End Page
738 / 738
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology